LivaNova (LIVN) EBT Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.82% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 32.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.06% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.57% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 14.40% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 41.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.18% |
| Dec 31, 2025 | 62.89% |
| Sep 30, 2025 | 32.37% |
| Jun 30, 2025 | 20.59% |
| Mar 31, 2025 | -288.59% |
| Dec 31, 2024 | 198.35% |
| Sep 30, 2024 | 45.33% |
| Jun 30, 2024 | 34.09% |
| Mar 31, 2024 | -6.80% |
| Dec 31, 2023 | 32.13% |
| Sep 30, 2023 | 52.72% |
| Jun 30, 2023 | 30.92% |
| Mar 31, 2023 | 53.63% |
| Dec 31, 2022 | 26.86% |
| Sep 30, 2022 | -90.77% |
| Jun 30, 2022 | 36.34% |
| Mar 31, 2022 | 31.22% |
| Dec 31, 2021 | 79.81% |
| Sep 30, 2021 | -66.94% |
| Jun 30, 2021 | -68.69% |
| Mar 31, 2021 | -48.45% |
| Dec 31, 2020 | -242.61% |
| Sep 30, 2020 | -38.18% |
| Jun 30, 2020 | -32.83% |
| Mar 31, 2020 | -31.77% |
| Dec 31, 2019 | -106.67% |
| Sep 30, 2019 | 0.27% |
| Jun 30, 2019 | -54.67% |
| Mar 31, 2019 | 17.99% |
| Dec 31, 2017 | 13.83% |